Y-QA-31

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameY-QA-31
Drug Alias NameY-QA31Y-QA-31
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor antagonists
TargetsDopamine D3 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Toxicants And Drugs, Academy Of Military Medical Sciences, Chinese People'S Liberation Army
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Toxicants And Drugs, Academy Of Military Medical Sciences, Chinese People'S Liberation Army
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A